These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 11551516)
41. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro. Chang SY; Chen C; Yang Z; Rodrigues AD Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483 [TBL] [Abstract][Full Text] [Related]
42. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50). Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892 [TBL] [Abstract][Full Text] [Related]
43. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells. Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399 [TBL] [Abstract][Full Text] [Related]
44. Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity. Caraco Y; Tateishi T; Guengerich FP; Wood AJ Drug Metab Dispos; 1996 Jul; 24(7):761-4. PubMed ID: 8818573 [TBL] [Abstract][Full Text] [Related]
45. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Heyn H; White RB; Stevens JC Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603 [TBL] [Abstract][Full Text] [Related]
46. Renal and hepatic accumulation of cadmium and lead in the expression of CYP4F2 and CYP2E1. Baker JR; Edwards RJ; Lasker JM; Moore MR; Satarug S Toxicol Lett; 2005 Nov; 159(2):182-91. PubMed ID: 15994032 [TBL] [Abstract][Full Text] [Related]
47. A comparative study of the effects of cadmium on microsomal mixed-function oxidase activities between kidney cortex and liver. Ding HP; Liu YG J Tongji Med Univ; 1992; 12(2):85-9. PubMed ID: 1433423 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase. Grimm SW; Dyroff MC Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599 [TBL] [Abstract][Full Text] [Related]
49. Inducibility of cytochromes P-450 by dioxin in liver and extrahepatic tissues of the marmoset monkey (Callithrix jacchus). Schulz TG; Neubert D; Davies DS; Edwards RJ Biochim Biophys Acta; 1996 Nov; 1298(1):131-40. PubMed ID: 8948497 [TBL] [Abstract][Full Text] [Related]
50. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes. Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607 [TBL] [Abstract][Full Text] [Related]
51. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129 [TBL] [Abstract][Full Text] [Related]
52. Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation. Stresser DM; Kupfer D Drug Metab Dispos; 1998 Sep; 26(9):868-74. PubMed ID: 9733665 [TBL] [Abstract][Full Text] [Related]
53. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes. Li Y; Li NY; Sellers EM Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924 [TBL] [Abstract][Full Text] [Related]
54. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily. Rodrigues AD; Roberts EM; Mulford DJ; Yao Y; Ouellet D Drug Metab Dispos; 1997 May; 25(5):623-30. PubMed ID: 9152603 [TBL] [Abstract][Full Text] [Related]
55. Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females. Ujjin P; Satarug S; Vanavanitkun Y; Daigo S; Ariyoshi N; Yamazaki H; Reilly PE; Moore MR; Kamataki T Pharmacogenetics; 2002 Apr; 12(3):241-9. PubMed ID: 11927840 [TBL] [Abstract][Full Text] [Related]
56. Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity. Baker JR; Satarug S; Edwards RJ; Moore MR; Williams DJ; Reilly PE Toxicol Lett; 2003 Jan; 137(1-2):85-93. PubMed ID: 12505434 [TBL] [Abstract][Full Text] [Related]
57. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602 [TBL] [Abstract][Full Text] [Related]
58. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism. Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Draper AJ; Madan A; Parkinson A Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352 [TBL] [Abstract][Full Text] [Related]
60. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]